Lexaria's Successful GLP-1 Agonist Pilot Study [keto gym gummies]

Lexaria's Successful GLP-1 Agonist Pilot Study [keto gym gummies]

| 1h 28m 28s | Video has closed captioning.

Unboxing Biotech Presents Lexaria Bioscience (LEXX). This short features CEO Chris Bunka who shares the company's plans for further evaluating DehydraTECH and GLP-1 agonists. These human an animal studies will explore weight loss and blood sugar control. See other videos in the series: Lexaria's Successful GLP-1 Agonist Pilot Study Lexaria's IND for DehydraTECH CBD Cleared by FDA Lexaria's GLP-1 Agonist Human Pilot Study Lexaria's Upcoming GLP-1 Agonist Studies Lexaria's Hypertension Program Explained Fireside Chat Lights Into Lexaria's DehydraTECH What Did We Learn From Lexaria' GLP-1 Study? Three Takeaways from Lexaria's Semaglutide Study See the company's presentation and further disclosures in the March 2024 presentation: